KR0140146B1 - 혈중 지방 함량을 강하시키기 위한 약학 조성물 - Google Patents

혈중 지방 함량을 강하시키기 위한 약학 조성물

Info

Publication number
KR0140146B1
KR0140146B1 KR1019940010049A KR19940010049A KR0140146B1 KR 0140146 B1 KR0140146 B1 KR 0140146B1 KR 1019940010049 A KR1019940010049 A KR 1019940010049A KR 19940010049 A KR19940010049 A KR 19940010049A KR 0140146 B1 KR0140146 B1 KR 0140146B1
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
acid
compound
formula
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019940010049A
Other languages
English (en)
Korean (ko)
Inventor
제이. 피터슨 마이클
Original Assignee
알렌 제이. 스피겔
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알렌 제이. 스피겔, 화이자 인코포레이티드 filed Critical 알렌 제이. 스피겔
Application granted granted Critical
Publication of KR0140146B1 publication Critical patent/KR0140146B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019940010049A 1993-05-10 1994-05-09 혈중 지방 함량을 강하시키기 위한 약학 조성물 Expired - Fee Related KR0140146B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/059,688 US5391551A (en) 1993-05-10 1993-05-10 Method of lowering blood lipid levels
US059,688 1993-05-10

Publications (1)

Publication Number Publication Date
KR0140146B1 true KR0140146B1 (ko) 1998-06-01

Family

ID=22024600

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940010049A Expired - Fee Related KR0140146B1 (ko) 1993-05-10 1994-05-09 혈중 지방 함량을 강하시키기 위한 약학 조성물

Country Status (10)

Country Link
US (1) US5391551A (enExample)
EP (1) EP0624369A1 (enExample)
JP (1) JP3153070B2 (enExample)
KR (1) KR0140146B1 (enExample)
CN (1) CN1047520C (enExample)
AU (1) AU657444B2 (enExample)
CA (1) CA2123059C (enExample)
IL (1) IL109517A (enExample)
TW (1) TW235919B (enExample)
ZA (1) ZA943203B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834466A (en) * 1994-12-22 1998-11-10 The Regents Of The University Of California Method for protecting of heart by limiting metabolic and ionic abnormalities developed during ischemia, following ischemia or resulting from ischemia
IL120264A0 (en) * 1996-02-29 1997-06-10 Pfizer Method of reducing tissue damage associated with non-cardiac ischemia
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
UA57811C2 (uk) * 1997-11-21 2003-07-15 Пфайзер Продактс Інк. Фармацевтична композиція, що містить інгібітор альдозоредуктази та інгібітор глікогенфосфорилази (варіанти), комплект, який її включає, та способи лікування ссавців зі станом інсулінорезистентності
HUP0101672A3 (en) * 1998-03-31 2002-05-28 Inst For Pharm Discovery Inc Substituted indolealkanoic acids
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
TNSN99224A1 (fr) * 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
JP6244425B2 (ja) * 2016-08-18 2017-12-06 花王株式会社 Ｇｌｐ−１分泌促進剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4492706A (en) * 1983-08-01 1985-01-08 American Home Products Corporation Method of lowering lipid levels
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
US4868301A (en) * 1987-06-09 1989-09-19 Pfizer Inc. Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains
EP0310931A3 (en) * 1987-10-08 1990-10-03 Ethyl Corporation Poultry feed
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels

Also Published As

Publication number Publication date
AU657444B2 (en) 1995-03-09
EP0624369A1 (en) 1994-11-17
US5391551A (en) 1995-02-21
CA2123059A1 (en) 1994-11-11
JP3153070B2 (ja) 2001-04-03
JPH08165241A (ja) 1996-06-25
CA2123059C (en) 1997-01-21
CN1047520C (zh) 1999-12-22
TW235919B (enExample) 1994-12-11
IL109517A (en) 1998-08-16
IL109517A0 (en) 1994-08-26
AU6196694A (en) 1994-12-01
ZA943203B (en) 1995-11-09
CN1103783A (zh) 1995-06-21

Similar Documents

Publication Publication Date Title
EP0792643B1 (en) Use of an aldose reductase inhibitor for reducing non-cardiac tissue damage
KR0140146B1 (ko) 혈중 지방 함량을 강하시키기 위한 약학 조성물
US4492706A (en) Method of lowering lipid levels
US5420135A (en) Substituted quinoline derivatives
JPH10316588A (ja) 糖尿病性心筋症の予防または逆転におけるアルドースレダクターゼ阻害
US4798835A (en) dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
CA2048235C (en) Lowering of blood uric acid levels
JPH02233683A (ja) シンノリン誘導体およびその製造方法
EP0505226B1 (en) Active oxygen scavenger
KR20000035869A (ko) 근조직 변성의 예방 또는 치료제
JP3357378B2 (ja) 糖尿病処置用のオキシランカルボン酸
US4895843A (en) Use of 3-(4-bromo-2-fluorobenzyl)-4-oxo-3H-phthalazin-1-ylacetic acid as a hypouricaemic agent
JP3154298B2 (ja) 製薬上活性の３―アリール及び３―ヘテロアリール―２―フルオロ―１―オレフィン類
EP0053379A1 (en) Anti-peptic ulcer agent
JPH0753380A (ja) 高脂血症治療剤及び高尿酸血症治療剤

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20020311

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20030311

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20030311

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000